Brief Report: Surveillance of Congenital Anomalies After Exposure to Raltegravir or Elvitegravir During Pregnancy in the United Kingdom and Ireland, 2008

Brief Report: Surveillance of Congenital Anomalies After Exposure to Raltegravir or Elvitegravir During Pregnancy in the United Kingdom and Ireland, 2008–2018

Published:2019-03-01 Issue:3 Volume:80 Page:264-268
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Rasi Virginia,Cortina-Borja Mario,Peters Helen,Sconza Rebecca,Thorne Claire

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference18 articles.

1. Surveillance monitoring for safety of in utero antiretroviral therapy exposures: current strategies and challenges;Zash;Expert Opin Drug Saf.,2016

2. UK mother-to-child HIV transmission rates continue to decline: 2012–2014;Peters;Clin Infect Dis.,2017

3. Neural-tube defects with dolutegravir treatment from the time of conception;Zash;N Engl J Med.,2018

4. Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review;Hill;J Virus Erad.,2018

5. HIV treatment in pregnancy;Bailey;Lancet HIV.,2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrase inhibitor drugs during pregnancy and congenital anomalies: A case/non‐case study from the global pharmacovigilance database VigiBase®;Pharmacology Research & Perspectives;2024-07-31

2. First-trimester exposure to newer antiretroviral agents and congenital anomalies in a US cohort;AIDS;2024-06-11

3. Antiretroviral Therapy in Pregnancy: A 2023 Review of the Literature;Current HIV/AIDS Reports;2024-01-26

4. Antiretroviral Regimen and Pregnancy Outcomes of Women Living With Human Immunodeficiency Virus in a US Cohort;Infectious Diseases in Clinical Practice;2023-09-25

5. Congenital malformations and preeclampsia associated with integrase inhibitor use in pregnancy: A single-center analysis;PLOS ONE;2023-06-12